Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ4D0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,273
Award facts
- Contract value 100% obligated
- $43,273.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $43,273.15. The contract, awarded December 10, 2025, with an ultimate completion date of December 11, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle that runs through December 2026 and enables the supplier to furnish pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company holds significant contracting relationships with the Defense Logistics Agency and serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Dupixent, a biologic medication used to treat conditions such as atopic dermatitis and eosinophilic asthma, demonstrates AmerisourceBergen's capability to fulfill specialized pharmaceutical requirements within the military healthcare supply chain through competitively awarded contracts with firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DR26FJ4D0?
SPE2DR26FJ4D0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FJ4D0 worth?
The government has obligated $43,273 on SPE2DR26FJ4D0.
Is contract SPE2DR26FJ4D0 an order under another contract?
Yes. SPE2DR26FJ4D0 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ4D0 competed?
The extent of competition for SPE2DR26FJ4D0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award